49 results
Page 3 of 3
6-K
EX-99.3
xz710162nyimnhg
26 Feb 20
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
7:15am
6-K
EX-99.1
1uuxnx0srlw lown2
16 Jan 20
CONTROLLING INFLAMMATION JP Morgan Corporate Presentation January 2020
4:11pm
6-K
EX-99.3
w2p3ypig fysrj
7 Nov 19
Current report (foreign)
7:00am
20-F/A
rlvljssbq4w mmo8s8
29 Mar 19
Annual report (foreign) (amended)
4:23pm
6-K
EX-99.1
b8t2pk
28 Mar 19
InflaRx Full Year 2018 Financial & Operating Results
8:48am
6-K
EX-99.1
s4qbsuj
3 Jan 19
InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management
8:53am
6-K
EX-99.3
kwtbzkp0y216q bs
21 Nov 18
Current report (foreign)
8:34am
6-K
EX-99.1
z54a7lt
5 Jun 18
Current report (foreign)
12:00am